By otakuyassine3@gmail.com 
Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 4,500,000 shares, a decline of 19.5% from the December 31st total of 5,590,000 shares. Based on an average daily trading volume, of 877,500 shares, the short-interest ratio is presently 5.1 days. Approximately 4.3% of the shares of the company are short sold.
Analyst Ratings Changes
A number of analysts have recently commented on the company. The Goldman Sachs Group upped their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Keefe, Bruyette & Woods lowered their target price on Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating for the company in a research note on Friday, January 10th. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price for the company. Barclays increased their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Finally, Bank of America upped their price target on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Ryan Specialty has a consensus rating of “Hold” and a consensus target price of $74.40.
Get Our Latest Research Report on Ryan Specialty
Ryan Specialty Price Performance
RYAN stock traded up $0.08 during midday trading on Friday, reaching $66.69. The company had a trading volume of 959,457 shares, compared to its average volume of 936,214. Ryan Specialty has a 1-year low of $42.21 and a 1-year high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a 50 day moving average price of $66.80 and a 200-day moving average price of $66.58. The company has a market capitalization of $17.46 billion, a price-to-earnings ratio of 86.61, a price-to-earnings-growth ratio of 1.15 and a beta of 0.72.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting the consensus estimate of $0.41. The company had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.32 earnings per share. Equities research analysts expect that Ryan Specialty will post 1.82 earnings per share for the current year.
Insiders Place Their Bets
In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00. Following the sale, the director now directly owns 65,100 shares of the company’s stock, valued at $4,387,089. This represents a 34.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 338,296 shares of company stock worth $22,463,709 over the last 90 days. Corporate insiders own 11.10% of the company’s stock.
Institutional Trading of Ryan Specialty
Several institutional investors have recently added to or reduced their stakes in RYAN. ProShare Advisors LLC bought a new stake in Ryan Specialty in the second quarter valued at approximately $280,000. AQR Capital Management LLC acquired a new position in Ryan Specialty in the second quarter valued at approximately $261,000. The Manufacturers Life Insurance Company lifted its stake in Ryan Specialty by 295.1% in the second quarter. The Manufacturers Life Insurance Company now owns 92,718 shares of the company’s stock valued at $5,369,000 after buying an additional 69,253 shares during the period. Northwestern Mutual Wealth Management Co. lifted its stake in Ryan Specialty by 1,688.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,844 shares of the company’s stock valued at $165,000 after buying an additional 2,685 shares during the period. Finally, Teachers Retirement System of The State of Kentucky acquired a new position in Ryan Specialty in the second quarter valued at approximately $1,176,000. 84.82% of the stock is currently owned by institutional investors.
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
Receive News & Ratings for Ryan Specialty Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Ryan Specialty and related companies with MarketBeat.com’s FREE daily email newsletter.